LSI Europe

To date, LSI has hosted nine global summits — six in Southern California, three across Europe — and has welcomed more than 10,000 global executives. Too many events are light on real investors. That’s why we’ve built deep, lasting relationships with active VCs, PEs, and CVCs. and create an experience they show up for, year after year. We’re continuing to push the bar by bringing bold ideas and new capital into medtech. This year, we are thrilled to have Harry Stebbings, Founder of 20VC, join us to discuss lessons from the best founders, the AI landscape, and its impact on healthcare. Visit us here for more details:  https://www.lsieuropesummit.com/

EP Solutions develops technology that will help physicians achieve better outcomes for heart failure patients indicated for Cardiac Resynchronisation Therapy. Visit here for more details: https://www.lsieuropesummit.com/

The medtech industry is brimming with AI startups promising to revolutionize healthcare—but how many of those innovations are truly transformative? A panel at LSI Europe ’24 took a clear-eyed look at what it takes to move from promise to impact. The discussion, moderated by Andrew Pieprzyk of Hologic, featured Pau Rodriguez (Methinks AI), Dror Zur (Magentiq Eye), David Zakariaie (Senseye), and Gokce Gun (We Venture Capital), each bringing a distinct vantage point to the table. Together, they offered a grounded yet forward-looking perspective on how artificial intelligence is reshaping diagnostic workflows across stroke, colorectal cancer, mental health, and beyond. Visit here for more details:  https://www.flipgorilla.com/p/28478664580544725/show

Cross-border business development in medtech is rarely a straight line. Between regulatory complexity, reimbursement variability, cultural nuances, and market-specific needs, expanding into new regions requires more than a product—it demands a strategy. At a recent LSI medtech conference in Europe, panelists Eliane Schutte (Xeltis), Jeffrey Sirek (PRIA Healthcare), Pieter Wijffels (NLC Health Ventures), and Sabine Kapasi (Enira Consulting), led by moderator Ajay Nair (The Mullings Group), tackled the topic head-on. Drawing from firsthand experience across Europe, the United States, China, India, and the Middle East, they explored what it takes to succeed in cross-border business development—from diligence and IP to commercialization, licensing, and culture. Visit here for more details: https://www.lsieuropesummit.com/news/the-art-and-science-of-cross-border-business-development

Raising capital is always a challenge, but raising capital from family offices requires an entirely different playbook. That was the message from the LSI Europe ’24 panel, where entrepreneurs and investors broke down the unique advantages—and nuances—of working with family offices instead of traditional medtech venture capital. Moderated by Alexei Mlodinow, former CEO and co-founder of SIA, the conversation featured insights from Marie-Louise Little (TW Medical A/S), Tyler Wanke (Wanke Family Office), John Slump (Atraverse Medical), and Pablo Prieto (CG Health Ventures). Together, they offered a candid look at what it takes to earn trust, navigate timelines, and build relationships that can unlock transformational support for medtech companies. Visit here for more details:  https://www.lsieuropesummit.com/news/raising-capital-from-family-offices-a-playbook-for-founders